BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Phenobarbital sodium injection (Sezaby) readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Phenobarbital sodium injection (Sezaby)\,
  from ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07923734-9024@assetmemo.bio
DTSTAMP:20261121T005037Z
DTSTART;VALUE=DATE:20280331
DTEND;VALUE=DATE:20280401
SUMMARY:Phenobarbital sodium injection (Sezaby): Phase 4 readout est. (NCT0
 7923734)
DESCRIPTION:Phenobarbital sodium injection (Sezaby)\, phase 4\, Epilepsy.\n
 Study: Study of Electrocardiogram (ECG) Safety of Sezaby in Neonatal Seizu
 res\nEstimated primary completion: March 2028. This is a ClinicalTrials.go
 v estimate\, not a confirmed readout date\, and it can move.\nDrug page: h
 ttps://assetmemo.bio/drug/phenobarbital-sodium-injection-sezaby#upcoming-e
 vents\nRegistry record: https://clinicaltrials.gov/study/NCT07923734
URL:https://assetmemo.bio/drug/phenobarbital-sodium-injection-sezaby#upcomi
 ng-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
